发明名称 |
Arylsulfonamido-substituted hydrodxamic acids |
摘要 |
Disclosed are the compounds of formula I <IMAGE> (I) wherein R and R1 together with the chain to which they are attached or R1 and R2 together with the carbon atom to which they are attached form a ring; pharmaceutically acceptable prodrug derivatives and pharmaceutically salts thereof; methods of preparation thereof; pharmaceutical compositions comprising said compounds; and a method of inhibiting matrix-degrading metalloproteinase and of treating matrix-degrading metalloproteinase dependent conditions in mammals using such compounds.
|
申请公布号 |
US5672615(A) |
申请公布日期 |
1997.09.30 |
申请号 |
US19960613303 |
申请日期 |
1996.03.11 |
申请人 |
NOVARTIS CORPORATION |
发明人 |
MACPHERSON, LAWRENCE J.;PARKER, DAVID THOMAS |
分类号 |
A61K31/18;A61K31/341;A61K31/381;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/443;A61K31/445;C07C311/19;C07C311/29;C07C311/42;C07D207/09;C07D207/16;C07D211/26;C07D211/34;C07D211/58;C07D211/66;C07D213/42;C07D215/12;C07D223/10;C07D233/24;C07D257/04;C07D261/10;C07D277/06;C07D277/28;C07D307/16;C07D309/14;C07D313/18;C07D317/58;C07D317/62;C07D333/58;C07D335/02;C07D401/04;C07D401/12;C07D405/12;C07D413/12;C07D521/00;(IPC1-7):C07D213/42 |
主分类号 |
A61K31/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|